Page last updated: 2024-10-20

purine and Disease Exacerbation

purine has been researched along with Disease Exacerbation in 6 studies

1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.

Research Excerpts

ExcerptRelevanceReference
"Amyotrophic lateral sclerosis (ALS), Lou Gehrig's disease, is a progressive fatal neurodegenerative disease that involves both upper and lower motor neurons."5.43New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway. ( Kato, M; Kato, S; Kusano, T; Nishino, T, 2016)
"Amyotrophic lateral sclerosis (ALS), Lou Gehrig's disease, is a progressive fatal neurodegenerative disease that involves both upper and lower motor neurons."1.43New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway. ( Kato, M; Kato, S; Kusano, T; Nishino, T, 2016)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Zhao, JZ2
Wang, W2
Liu, T2
Zhang, L2
Lin, DZ2
Yao, JY2
Peng, X2
Jin, G2
Ma, TT2
Gao, JB2
Huang, F2
Nie, J2
Lv, Q2
Kong, T1
Ren, X1
Lin, S1
Li, S1
Gong, Y1
Sahu, D1
Lotan, Y1
Wittmann, B1
Neri, B1
Hansel, DE1
Chang, CH1
Bijian, K1
Wernic, D1
Su, J1
da Silva, SD1
Yu, H1
Qiu, D1
Asslan, M1
Alaoui-Jamali, MA1
Ma, F1
Zhu, Y1
Liu, X1
Zhou, Q1
Hong, X1
Qu, C1
Feng, X1
Zhang, Y1
Ding, Q1
Zhao, J1
Hou, J1
Zhong, M1
Zhuo, H1
Zhong, L1
Ye, Z1
Xie, W1
Liu, Y1
Xiong, Y1
Chen, H1
Piao, D1
Sun, B1
Gao, Z1
Li, Q1
Zhang, Z2
Qiu, X1
Kato, S1
Kato, M1
Kusano, T1
Nishino, T1

Other Studies

6 other studies available for purine and Disease Exacerbation

ArticleYear
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
Elucidation of metabolic responses in mud crab Scylla paramamosain challenged to WSSV infection by integration of metabolomics and transcriptomics.
    Developmental and comparative immunology, 2020, Volume: 113

    Topics: Animals; Arthropod Proteins; ATP-Binding Cassette Transporters; Brachyura; Disease Progression; DNA

2020
Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
    Cancer medicine, 2017, Volume: 6, Issue:9

    Topics: Aged; Carcinoma, Transitional Cell; Cell Line, Tumor; Chromatography, Liquid; Citric Acid Cycle; Dis

2017
A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Autophagy, 2019, Volume: 15, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Autophagy; Cell Line, Tumor; Cell Prolif

2019
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression.
    Hepatology (Baltimore, Md.), 2019, Volume: 70, Issue:5

    Topics: Activating Transcription Factor 4; Carcinoma, Hepatocellular; Disease Progression; Humans; Liver Neo

2019
New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway.
    Journal of neuropathology and experimental neurology, 2016, 12-01, Volume: 75, Issue:12

    Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Enzyme Inhibitors

2016